Clinical Trial: Low Dose Induction for Pediatric Acute Myeloid Leukemia Patients

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07867600) titled 'Low Dose Induction for Pediatric Acute Myeloid Leukemia Patients' on Sept. 28.

Brief Summary: the standard induction treatment for pediatric acute myeloid leukemia has high early morbidity and mortality that jeopardize the outcome especially in developing countries. SIOP recommended lower dose induction synergistic G- CSF to minimize these unwanted toxicities. the study aimed at minimizing the toxicities during induction without jeopardizing the survival.

Study Start Date: July 28, 2022

Study Type: INTERVENTIONAL

Condition: Pediatric Acute Myeloid Leukemia Induction

Intervention: COMBINATION_PRODUCT: Low dose Ara C/ anthracycl...